MongoDB
MDB
363.03
+2.32
+0.64%
MongoDB
US · MDB
#715 by market cap
Listed 2017
363.03
+2.32
+0.64%
Live - 5344 symbols - heartbeat 397s ago
· 2026-10-08 07:39
Pre-market
362.10
-0.26%
After-hours
363.04
+0.00%
Overnight
361.53
-0.41%
- Market cap
- 29.24B
- P/E (TTM)i
- 511.31
- P/Bi
- 9.81
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on MDB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 22.36, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +22.79% YoY
Margins
- Gross margin
- 71.75%
- Operating margin
- -5.56%
- Net margin
- -2.89%
Key ratios & quality
- Altman Z-Scorei
- 22.36
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 267.02M | 421.72M | 590.38M | 873.78M | 1.28B | 1.68B | 2.01B | 2.46B |
| Gross profit | 193.45M | 296.36M | 413.30M | 614.29M | 934.74M | 1.26B | 1.47B | 1.77B |
| Selling & admin expenses | 201.36M | 295.20M | 417.45M | 594.83M | 859.70M | 976.32M | 1.09B | 1.19B |
| Research & development | 89.85M | 149.03M | 205.16M | 308.82M | 421.69M | 515.94M | 596.84M | 716.30M |
| Operating profit | -97.77M | -147.87M | -209.30M | -289.36M | -346.66M | -233.73M | -216.06M | -136.97M |
| Pretax profit | -102.33M | -176.18M | -262.69M | -302.89M | -333.25M | -163.52M | -131.60M | -55.69M |
| Tax | -3.32M | -656.00K | 4.25M | 3.98M | 12.14M | 13.08M | -2.53M | 15.46M |
| Net profit | -99.01M | -175.52M | -266.94M | -306.87M | -345.40M | -176.60M | -129.07M | -71.15M |
| Basic EPS | -2 | -3 | -5 | -5 | -5 | -2 | -2 | -1 |
| Diluted EPS | -1.90 | -3.14 | -4.53 | -4.75 | -5.03 | -2.48 | -1.73 | -0.88 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 549.01M | 591.40M | 628.31M | 695.07M | 687.62M | 771.77M |
| Gross profit | 390.97M | 419.97M | 449.13M | 507.66M | 496.18M | 569.77M |
| Selling & admin expenses | 275.70M | 303.53M | 290.95M | 318.23M | 320.57M | 327.49M |
| Research & development | 168.83M | 181.74M | 176.61M | 189.13M | 200.41M | 213.87M |
| Operating profit | -53.55M | -65.29M | -18.42M | 304.00K | -24.80M | 28.40M |
| Pretax profit | -33.32M | -43.12M | 1.35M | 19.40M | 8.79M | 45.95M |
| Tax | 4.30M | 3.93M | 3.36M | 3.87M | 4.36M | 5.01M |
| Net profit | -37.63M | -47.05M | -2.01M | 15.53M | 4.43M | 40.94M |
| Basic EPS | 0 | -1 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.46 | -0.58 | -0.02 | 0.18 | 0.05 | 0.50 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 566.24M | 1.11B | 1.14B | 2.12B | 2.24B | 2.48B | 2.92B | 3.11B |
| Cash & ST investments | 465.97M | 986.52M | 957.74M | 1.83B | 1.84B | 2.02B | 2.34B | 2.39B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 733.48M | 1.33B | 1.41B | 2.45B | 2.59B | 2.87B | 3.43B | 3.76B |
| Total current liabilities | 164.64M | 242.38M | 354.54M | 526.74M | 588.51M | 564.22M | 561.99M | 669.50M |
| Short-term debt | -- | 3.75M | 2.34M | 8.08M | 8.69M | 9.80M | 9.13M | 9.26M |
| Long-term debt | 216.86M | 911.08M | 937.73M | 1.14B | 1.14B | 1.14B | -- | -- |
| Total liabilities | 468,910,000.00 | 1,245,709,000.00 | 1,407,814,000.00 | 1,782,888,000.00 | 1,849,385,000.00 | 1,800,653,000.00 | 648,069,000.00 | 806,490,000.00 |
| Total equity | 264.57M | 82.86M | -319.00K | 666.70M | 739.51M | 1.07B | 2.78B | 2.95B |
| Retained earnings | -488.61M | -668.23M | -935.40M | -1.19B | -1.54B | -1.71B | -1.84B | -1.91B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.97B | 2.90B | 2.93B | 3.11B | 3.06B | 3.13B |
| Cash & ST investments | 2.45B | 2.35B | 2.31B | 2.39B | 2.43B | 2.41B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.62B | 3.54B | 3.57B | 3.76B | 3.69B | 3.78B |
| Total current liabilities | 505.00M | 509.83M | 558.03M | 669.50M | 618.18M | 642.37M |
| Short-term debt | 8.91M | 9.51M | 9.15M | 9.26M | 9.36M | 9.37M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 591,470,000.00 | 599,087,000.00 | 678,210,000.00 | 806,490,000.00 | 757,731,000.00 | 797,708,000.00 |
| Total equity | 3.03B | 2.94B | 2.89B | 2.95B | 2.93B | 2.98B |
| Retained earnings | -1.88B | -1.93B | -1.93B | -1.91B | -1.91B | -1.87B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -41.99M | -29.54M | -42.67M | 6.98M | -12.97M | 121.48M | 150.19M | 505.15M |
| Depreciation & amortization | 5.79M | 19.77M | 24.53M | 24.46M | 29.18M | 32.13M | 26.97M | 37.41M |
| Free cash flow | -48.84M | -33.10M | -54.45M | -1.09M | -20.21M | 115.40M | 120.64M | 500.19M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | 889.18M | -- | 0 | 0 | -400.33M |
| Ending cash balance | 148.35M | 706.71M | 430.22M | 474.42M | 456.34M | 803.64M | 492.75M | 1.09B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 109.93M | 72.11M | 143.51M | 179.60M | 201.63M | 141.88M |
| Depreciation & amortization | 9.06M | 9.51M | 9.56M | 9.28M | 9.13M | 9.53M |
| Free cash flow | 108.32M | 71.57M | 141.83M | 178.47M | 199.31M | 139.41M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -194.45M | -148.63M | -57.25M | -100.26M | -100.00M |
| Ending cash balance | 660.44M | 650.21M | 837.17M | 1.09B | 1.04B | 1.01B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -43.23 | -101.04 | -646.83 | -92.10 | -49.12 | -19.53 | -6.70 | -2.48 |
| ROA %i | -17.24 | -17.02 | -19.51 | -15.91 | -13.71 | -6.47 | -4.10 | -1.98 |
| ROIC %i | -21.53 | -21.88 | -23.11 | -21.15 | -18.90 | -10.98 | -8.48 | -4.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -185.55 | -181.73 | -162.86 | -33.99 |
| EBIT margin %i | -34.47 | -36.80 | -34.99 | -33.37 | -25.19 | -9.16 | -6.16 | -2.13 |
| FCF / sales %i | -- | -- | -- | -- | -- | 6.86 | 6.01 | 20.30 |
| Current ratioi | 3.44 | 4.59 | 3.22 | 4.02 | 3.80 | 4.40 | 5.20 | 4.65 |
| Quick ratioi | 3.27 | 4.42 | 3.08 | 3.84 | 3.61 | 4.15 | 4.86 | 4.31 |
| Debt / assetsi | 29.57 | 69.47 | 69.57 | 48.31 | 45.77 | 41.26 | 1.06 | 0.87 |
| LT debt / equityi | 81.97 | 1,109.35 | -- | 176.28 | 159.04 | 109.84 | 0.98 | 0.80 |
| Interest coveragei | -8.94 | -7.40 | -3.68 | -25.77 | -33.02 | -16.42 | -15.26 | -16.80 |
| Revenue CAGR (3Y) %i | 59.93 | 54.30 | 52.63 | 48.46 | 44.94 | 41.79 | 31.93 | 24.26 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -4.00 | -3.65 | -3.23 | -2.48 | -0.97 | 1.99 |
| ROA %i | -2.59 | -2.36 | -2.09 | -1.98 | -0.80 | 1.61 |
| ROIC %i | -6.30 | -6.03 | -5.67 | -4.22 | -2.59 | -0.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -3.78 | -3.29 | -2.85 | -2.13 | -0.41 | 2.80 |
| FCF / sales %i | 7.88 | 10.82 | 14.94 | 20.30 | 22.72 | 23.68 |
| Current ratioi | 5.89 | 5.70 | 5.25 | 4.65 | 4.95 | 4.87 |
| Quick ratioi | 5.48 | 5.29 | 4.88 | 4.31 | 4.55 | 4.47 |
| Debt / assetsi | 1.02 | 1.01 | 0.97 | 0.87 | 0.82 | 0.76 |
| LT debt / equityi | 0.93 | 0.89 | 0.88 | 0.80 | 0.72 | 0.65 |
| Interest coveragei | -10.97 | -11.31 | -13.26 | -16.80 | -3.66 | 32.91 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Atlas-related is the largest reported line at 73.33% of revenue, across 3 reported segments.
- The next-largest line, MongoDB Enterprise Advanced and other, is a distant second at 23.48% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Atlas-related73.33%
MongoDB Enterprise Advanced and other23.48%
Services3.19%
Quote time 2026-10-08 07:39:29 · For reference only, not investment advice and not tailored to your situation.